This eLearning module presents Section 4 of the WFH Guidelines for the Management of Hemophilia: Hemostatic Agents. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life the WFH recommendations regarding FVIII and FIX clotting factor concentrates, fresh frozen plasma, cryoprecipitate, and other pharmacological options including DDAVP, tranexamic acid, and epsilon aminocaproic acid. Safety, dosage, and administration are considered for each product. Target factor peak level recommendations are made for contexts with and without significant resource constraints.

Instructions

Click on the « View Resource » button above to launch the module. Click on the NEXT and PREV buttons in the bottom right corner to move forward and backward through the module, or jump to a specific section by selecting it from the Table of Contents on the bottom left. The second screen presents all the interactive features of the module and how to use them. Click Help in the upper right corner of the screen at any time to return to this screen.

Evidence based practice statements are highlighted in red text, glossary terms are highlighted in blue. Look up definitions by clicking Glossary in the top right of the screen. Full-text supplementary resources are available by clicking Resources in the top right corner, including a pdf of the full Guidelines for the Management of Hemophilia. Click the interactive icons to access more essential information:

Note

Information

Slideshow

Side notes

If you have previously viewed the module the player may ask whether you wish to resume the presentation where you left off last time. In that case you can choose either to continue from the point where you stopped last time (Yes) or start again at the beginning (No).